Sign in Subscribe
Class action lawsuits

Pomerantz LLP Announces Class Action Lawsuit Against Hims & Hers Health, Inc.

Strategic Insights

— 1 min read

Pomerantz LLP has announced a class action lawsuit against Hims & Hers Health, Inc. ("Hims & Hers") due to allegations of securities fraud and other unlawful business practices. The law firm is seeking to appoint a lead plaintiff for the class of investors who purchased or acquired Hims & Hers securities during the Class Period. On April 29, 2025, Hims & Hers announced a long-term collaboration with Novo Nordisk, which was terminated on June 23, 2025, due to allegations of deceptive promotion and selling of illegitimate versions of Wegovy(R).

Key Takeaways:

  • Hims & Hers is facing a class action lawsuit for allegedly engaging in securities fraud and other unlawful business practices.
  • The lawsuit concerns the company's collaboration with Novo Nordisk, which was terminated on June 23, 2025, due to allegations of deceptive promotion and selling of illegitimate versions of Wegovy(R).
  • The company's stock price fell $22.24 per share, or 34.63%, to close at $41.98 per share on June 23, 2025.
  • Pomerantz LLP, a leading law firm in the areas of corporate, securities, and antitrust class litigation, has filed the lawsuit.
  • The firm has recovered numerous multimillion-dollar damages awards on behalf of class members.
  • The law firm is seeking to appoint a lead plaintiff for the class of investors who purchased or acquired Hims & Hers securities during the Class Period.

Statistics:

  • Hims & Hers' stock price fell $22.24 per share, or 34.63%, to close at $41.98 per share on June 23, 2025.
  • The company's collaboration with Novo Nordisk was terminated on June 23, 2025.
  • The lawsuit concerns the company's actions during the Class Period, which expired on August 25, 2025.
  • Pomerantz LLP has recovered numerous multimillion-dollar damages awards on behalf of class members.
  • The firm has offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv.

Sources:

  • GlobeNewswire, "Pomerantz LLP Announces Class Action Lawsuit Against Hims & Hers Health, Inc.", Aug. 05, 2025
  • Hims & Hers Health, Inc. official website, "Hims & Hers announces collaboration with Novo Nordisk"
  • Novo Nordisk official website, "Novo Nordisk Terminates Partnership with Hims & Hers Citing Deceptive Practices"
  • Pomerantz LLP website, "Pomerantz LLP Announces Class Action Lawsuit Against Hims & Hers Health, Inc."
  • Pomerantz LLP website, "Pomerantz LLP's History and Achievements"

Read more